Krystal Biotech (KRYS) Market Cap 2017–2026

As of October 29, 2026, Krystal Biotech had a market cap of $9.605 billion, which increased by 0.97% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Oct 29, 2026, 4:00 PM ET
Krystal Biotech logo

Krystal Biotech, Inc. (KRYS)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Biotechnology
Latest Market Cap
$9.605B ▲ 0.97%
Start of 2026
$7.149B ▲ 34.35%
1 Year Ago
$5.483B ▲ 75.17%
All-Time High
$11.13B ▼ 13.70%


Loading data...


Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Krystal Biotech Market Cap History by Year and Month

Krystal Biotech Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$9.605B▲ 34.35%
$9.605B▼ 2.41%
$9.842B▼ 7.50%
$10.64B▲ 5.98%
$10.04B▼ 8.23%
$10.94B▲ 20.09%
$9.11B▲ 18.01%
$7.72B▲ 2.24%
$7.551B▼ 6.29%
$8.058B▼ 0.48%
$8.097B▲ 13.26%
2025$7.149B▲ 58.51%
2024$4.51B▲ 28.86%
2023$3.5B▲ 71.57%
2022$2.04B▲ 15.71%
All market cap values reflect closing prices for the period shown.

📊 Krystal Biotech Market Cap and Other Industry Peers

Below are selected companies from the Biotechnology sector / subsector:


Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.